Received Jul 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | LA |
Blisters; This serious case was reported by a physician via sales rep and described the occurrence of blister in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 15-MAY-2025, the patient received Shingles vaccine (left deltoid). On 15-MAY-2025, less than a day after receiving Shingles vaccine, the patient experienced blister (Verbatim: Blisters) (serious criteria other: serious as per reporter). The outcome of the blister was not resolved. The reporter considered the blister to be related to Shingles vaccine. The company considered the blister to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 15-MAY-2025 The patient had blisters after received a subsequent dose of Shingles vaccine. It persisted and tended to spread to additional areas. No other products were received by the patient.; Sender's Comments: A case of Blister, less than a day after receiving Shingles vaccine, in a female patient. Based on the available information, a possible causality that the event(s) was caused by the GSK product cannot be ascertained. Further follow up information has been sought.